How Baxter International's dividend compares to Gilead

Press/Media: Research

Period	Feb 18 2025

Media coverage

Title How Baxter International's dividend compares to Gilead
Media name/outlet Global Round Up - Sectors
Country/Territory United Kingdom
Date 2/18/25
Persons Robert P. Smith
Title How Baxter International's dividend compares to Amgen
Media name/outlet Global Round Up - Sectors
Country/Territory United Kingdom
Date 2/18/25
Persons Robert P. Smith
Title How Baxter International's dividend compares to BD
Media name/outlet Global Round Up - Sectors
Country/Territory United Kingdom
Date 2/18/25
Persons Robert P. Smith
Title Baxter International continues to underperform Gilead by 7.0% year to date
Media name/outlet Global Round Up - Sectors
Country/Territory United Kingdom
Date 2/18/25
Persons Robert P. Smith

Title	How Baxter International's dividend compares to Gilead
Media name/outlet	Global Round Up - Sectors
Country/Territory	United Kingdom
Date	2/18/25
Persons	Robert P. Smith

Title	How Baxter International's dividend compares to Amgen
Media name/outlet	Global Round Up - Sectors
Country/Territory	United Kingdom
Date	2/18/25
Persons	Robert P. Smith

Title	How Baxter International's dividend compares to BD
Media name/outlet	Global Round Up - Sectors
Country/Territory	United Kingdom
Date	2/18/25
Persons	Robert P. Smith

Title	Baxter International continues to underperform Gilead by 7.0% year to date
Media name/outlet	Global Round Up - Sectors
Country/Territory	United Kingdom
Date	2/18/25
Persons	Robert P. Smith

Title	Baxter International continues to underperform Alnylam Pharmaceuticals by 3.3% year to date
Media name/outlet	Global Round Up - Sectors
Country/Territory	United Kingdom
Date	2/18/25
Persons	Robert P. Smith

Title Baxter International continues to underperform Amgen by 6.0% year to date
Media name/outlet Global Round Up - Sectors
Country/Territory United Kingdom
Date 2/18/25
Persons Robert P. Smith
Title Baxter International continues to outperform Regeneron by 11.1% year to date
Media name/outlet Global Round Up - Sectors
Country/Territory United Kingdom
Date 2/18/25
Persons Robert P. Smith
Title Baxter International's Earnings Growth Lags Gilead
Media name/outlet Global Round Up - Sectors
Country/Territory United Kingdom
Date 2/18/25
Persons Robert P. Smith
Title Baxter International's Earnings Growth Outperforms Amgen
Media name/outlet Global Round Up - Sectors
Country/Territory United Kingdom
Date 2/18/25
Persons Robert P. Smith
Title Baxter International's Earnings Growth Outperforms Regeneron
Media name/outlet Global Round Up - Sectors
Country/Territory United Kingdom
Date 2/18/25
Persons Robert P. Smith
Title Baxter International's Earnings Growth Outperforms Vertex Pharmaceuticals
Media name/outlet Global Round Up - Sectors
Country/Territory United Kingdom
Date 2/18/25
Persons Robert P. Smith

Title	Baxter International continues to underperform Amgen by 6.0% year to date
Media name/outlet	Global Round Up - Sectors
Country/Territory	United Kingdom
Date	2/18/25
Persons	Robert P. Smith

Title	Baxter International continues to outperform Regeneron by 11.1% year to date
Media name/outlet	Global Round Up - Sectors
Country/Territory	United Kingdom
Date	2/18/25
Persons	Robert P. Smith

Title	Baxter International's Earnings Growth Lags Gilead
Media name/outlet	Global Round Up - Sectors
Country/Territory	United Kingdom
Date	2/18/25
Persons	Robert P. Smith

Title	Baxter International's Earnings Growth Outperforms Amgen
Media name/outlet	Global Round Up - Sectors
Country/Territory	United Kingdom
Date	2/18/25
Persons	Robert P. Smith

Title	Baxter International's Earnings Growth Outperforms Regeneron
Media name/outlet	Global Round Up - Sectors
Country/Territory	United Kingdom
Date	2/18/25
Persons	Robert P. Smith

Title	Baxter International's Earnings Growth Outperforms Vertex Pharmaceuticals
Media name/outlet	Global Round Up - Sectors
Country/Territory	United Kingdom
Date	2/18/25
Persons	Robert P. Smith